Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Issued Shares

Bulletin Express01-19

Qyuns Therapeutics Co., Ltd. (stock code: 02509) disclosed a Next Day Disclosure Return dated January 19, 2026, highlighting a repurchase of 53,000 H shares on January 19, 2026. According to the information, the repurchase price ranged between HKD 21.98 and HKD 23.08 per share, resulting in a total aggregate price of HKD 1,181,836.4.

Qyuns Therapeutics reported that its issued shares (excluding treasury shares) stood at 225,286,000 as of January 16, 2026, and decreased to 225,233,000 following the repurchase transaction. Meanwhile, treasury shares increased from 1,785,600 to 1,838,600, keeping the total number of issued shares at 227,071,600.

The purchased 53,000 shares were classified as treasury shares, with no shares canceled. A new share issuance or a sale of treasury shares is subject to a 30-day moratorium period ending on February 18, 2026, in accordance with the applicable rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1178108312?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-19 20:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178108312","market":"us","top_or_hot":-1,"title":"Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Issued Shares","media":"Bulletin Express","content":"<p>Qyuns Therapeutics Co., Ltd. (stock code: 02509) disclosed a Next Day Disclosure Return dated January 19, 2026, highlighting a repurchase of 53,000 H shares on January 19, 2026. According to the information, the repurchase price ranged between HKD 21.98 and HKD 23.08 per share, resulting in a total aggregate price of HKD 1,181,836.4.</p>\n<p>Qyuns Therapeutics reported that its issued shares (excluding treasury shares) stood at 225,286,000 as of January 16, 2026, and decreased to 225,233,000 following the repurchase transaction. Meanwhile, treasury shares increased from 1,785,600 to 1,838,600, keeping the total number of issued shares at 227,071,600.</p>\n<p>The purchased 53,000 shares were classified as treasury shares, with no shares canceled. A new share issuance or a sale of treasury shares is subject to a 30-day moratorium period ending on February 18, 2026, in accordance with the applicable rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Issued Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQyuns Therapeutics (02509) Announces Share Repurchase and Updated Issued Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-19 20:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Qyuns Therapeutics Co., Ltd. (stock code: 02509) disclosed a Next Day Disclosure Return dated January 19, 2026, highlighting a repurchase of 53,000 H shares on January 19, 2026. According to the information, the repurchase price ranged between HKD 21.98 and HKD 23.08 per share, resulting in a total aggregate price of HKD 1,181,836.4.</p>\n<p>Qyuns Therapeutics reported that its issued shares (excluding treasury shares) stood at 225,286,000 as of January 16, 2026, and decreased to 225,233,000 following the repurchase transaction. Meanwhile, treasury shares increased from 1,785,600 to 1,838,600, keeping the total number of issued shares at 227,071,600.</p>\n<p>The purchased 53,000 shares were classified as treasury shares, with no shares canceled. A new share issuance or a sale of treasury shares is subject to a 30-day moratorium period ending on February 18, 2026, in accordance with the applicable rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"","article_id":"1178108312","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178108312","pubTimestamp":1768826495,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Qyuns Therapeutics Co., Ltd. (stock code: 02509) disclosed a Next Day Disclosure Return dated January 19, 2026, highlighting a repurchase of 53,000 H shares on January 19, 2026. According to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02509":"荃信生物-B"},"translate_title":"Qyuns Therapeutics(02509)公布购回股份及更新已发行股份","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1},"content_text":"Qyuns Therapeutics Co., Ltd. (stock code: 02509) disclosed a Next Day Disclosure Return dated January 19, 2026, highlighting a repurchase of 53,000 H shares on January 19, 2026. According to the information, the repurchase price ranged between HKD 21.98 and HKD 23.08 per share, resulting in a total aggregate price of HKD 1,181,836.4.\nQyuns Therapeutics reported that its issued shares (excluding treasury shares) stood at 225,286,000 as of January 16, 2026, and decreased to 225,233,000 following the repurchase transaction. Meanwhile, treasury shares increased from 1,785,600 to 1,838,600, keeping the total number of issued shares at 227,071,600.\nThe purchased 53,000 shares were classified as treasury shares, with no shares canceled. A new share issuance or a sale of treasury shares is subject to a 30-day moratorium period ending on February 18, 2026, in accordance with the applicable rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1178108312","isCrawlerRequest":true}